Case File
efta-efta00852631DOJ Data Set 9OtherFrom: Jeffrey Port II=In
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00852631
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Port II=In
To: jeevacation®gmail.com
Cc: 'PW F'
Subject:
Date: Thu, 02 Jul 2015 14:41:30 +0000
Attachments: Angiocrine_Bioscience_Confidential_NUMBERS_deck_Jun_2015_v 150701.pptx
Jeff
Hope all well
Wanted to provide the numbers for Angiocrine
In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation.
We are offering a 25% discount to the series b, and looking to bolster our financials for the raise with an additional 5
million in capital.
Overall, I think a very good deal . Paul Finnegan , our CEO, and I are available next week in NY if you wish to discuss live
If you have interest let me know
Best regards
Jeff Port (c)
EFTA00852631
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
gmail.comForum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.